Index RUT
P/E -
EPS (ttm) -3.64
Insider Own 2.56%
Shs Outstand 31.39M
Perf Week -1.06%
Market Cap 3.16B
Forward P/E -
EPS next Y -0.62
Insider Trans -11.07%
Shs Float 30.61M
Perf Month -9.44%
Income -113.29M
PEG -
EPS next Q -0.98
Inst Own 109.30%
Short Float 9.63%
Perf Quarter 15.85%
Sales 591.84M
P/S 5.34
EPS this Y 53.86%
Inst Trans 0.28%
Short Ratio 6.75
Perf Half Y 34.53%
Book/sh 2.90
P/B 34.76
EPS next Y 63.04%
ROA -16.60%
Short Interest 2.95M
Perf Year -4.92%
Cash/sh 17.05
P/C 5.90
EPS next 5Y -
ROE -75.27%
52W Range 55.92 - 128.52
Perf YTD 11.64%
Dividend Est. -
P/FCF -
EPS past 5Y -10.95%
ROI -13.95%
52W High -21.67%
Beta 1.47
Dividend TTM -
Quick Ratio 5.70
Sales past 5Y 22.53%
Gross Margin 68.86%
52W Low 80.03%
ATR (14) 5.33
Dividend Ex-Date -
Current Ratio 5.82
EPS Y/Y TTM 10.05%
Oper. Margin -13.94%
RSI (14) 42.88
Volatility 4.90% 4.91%
Employees 2000
Debt/Eq 8.11
Sales Y/Y TTM 20.13%
Profit Margin -19.14%
Recom 1.38
Target Price 133.00
Option/Short Yes / Yes
LT Debt/Eq 7.93
EPS Q/Q 96.63%
Payout -
Rel Volume 0.75
Prev Close 97.77
Sales Surprise 3.94%
EPS Surprise 87.92%
Sales Q/Q 24.01%
Earnings Feb 20 AMC
Avg Volume 436.24K
Price 100.67
SMA20 -6.69%
SMA50 -4.93%
SMA200 14.90%
Trades
Volume 326,875
Change 2.97%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-03-24 Resumed
Wells Fargo
Equal Weight
$86
Oct-04-24 Initiated
Goldman
Neutral
$78
Jun-20-24 Upgrade
Wolfe Research
Peer Perform → Outperform
$115
Dec-11-23 Upgrade
Citigroup
Neutral → Buy
$110
Jul-19-23 Initiated
Robert W. Baird
Outperform
$130
Feb-07-23 Initiated
Wells Fargo
Overweight
$150
Nov-07-22 Upgrade
Wolfe Research
Underperform → Peer Perform
Jun-09-22 Downgrade
Citigroup
Buy → Neutral
$180 → $155
Apr-06-22 Initiated
Wolfe Research
Underperform
$105
Feb-24-22 Upgrade
Needham
Hold → Buy
$135
Feb-24-22 Upgrade
Needham
Hold → Buy
Jan-18-22 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$129 → $167
Jan-12-22 Upgrade
BTIG Research
Neutral → Buy
$170
Jan-11-22 Upgrade
Oppenheimer
Perform → Outperform
$150
Dec-21-21 Resumed
Canaccord Genuity
Buy
$125
Dec-17-21 Upgrade
JP Morgan
Neutral → Overweight
$100 → $116
Dec-15-21 Upgrade
Citigroup
Neutral → Buy
$120
Jun-02-21 Downgrade
Citigroup
Buy → Neutral
$105 → $78
Apr-13-21 Downgrade
BTIG Research
Buy → Neutral
Apr-12-21 Downgrade
JP Morgan
Overweight → Neutral
Show Previous Ratings
Mar-11-25 05:07AM
Mar-05-25 08:03AM
Feb-21-25 02:15AM
Feb-20-25 11:57PM
05:27PM
05:25PM
Loading…
05:25PM
04:05PM
Feb-19-25 08:01AM
Feb-13-25 10:01AM
Feb-06-25 04:05PM
Jan-18-25 07:55AM
Jan-14-25 09:05AM
Jan-13-25 08:30AM
Dec-30-24 04:30PM
Dec-19-24 07:30AM
04:30PM
Loading…
Nov-20-24 04:30PM
Nov-18-24 10:00AM
08:15AM
Nov-05-24 04:30PM
Nov-01-24 08:49AM
07:45AM
Oct-31-24 03:16AM
Oct-30-24 06:35PM
05:15PM
04:08PM
Oct-28-24 08:02AM
Oct-23-24 07:47AM
06:00AM
Oct-22-24 01:18PM
12:24PM
08:56AM
Loading…
08:56AM
07:36AM
Oct-21-24 04:05PM
Oct-16-24 04:05PM
07:57AM
Oct-11-24 06:57AM
Oct-04-24 04:45AM
Sep-12-24 04:32AM
Sep-11-24 08:05AM
Sep-09-24 08:05AM
Sep-04-24 07:30AM
02:00AM
Sep-01-24 01:33PM
Aug-29-24 08:00AM
Aug-21-24 04:05PM
Aug-07-24 12:00PM
Aug-02-24 12:15AM
Aug-01-24 06:15PM
04:06PM
04:05PM
Jul-22-24 11:00AM
Jul-21-24 10:00AM
Jul-18-24 04:05PM
Jul-14-24 09:15AM
Jun-28-24 07:28PM
Jun-23-24 12:19AM
Jun-17-24 04:05PM
Jun-05-24 03:00PM
Jun-04-24 04:05PM
May-22-24 04:05PM
May-05-24 08:36AM
May-03-24 10:05AM
07:05AM
(Thomson Reuters StreetEvents)
May-02-24 10:54PM
05:39PM
04:05PM
09:45AM
Apr-23-24 12:35PM
Apr-18-24 04:05PM
Apr-08-24 04:09AM
Apr-01-24 05:45AM
Mar-20-24 05:45AM
Mar-13-24 11:30AM
Mar-08-24 04:30PM
Mar-05-24 11:29PM
Mar-04-24 11:42PM
06:45AM
Feb-29-24 04:30PM
Feb-23-24 12:30PM
11:06AM
05:45AM
Feb-22-24 05:50PM
04:36PM
04:05PM
Feb-20-24 01:59PM
05:45AM
Feb-08-24 04:05PM
Jan-14-24 12:54PM
Jan-08-24 08:30AM
Jan-05-24 08:05AM
Jan-04-24 07:01PM
Jan-03-24 08:00AM
Dec-26-23 04:30PM
Nov-13-23 08:05AM
Nov-03-23 10:41AM
09:44AM
(Thomson Reuters StreetEvents)
Nov-02-23 06:22PM
04:05PM
Oct-31-23 10:01AM
Oct-27-23 09:35AM
iRhythm Technologies, Inc. is a digital healthcare company, which engages in the provision of design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services. It also provides solutions that detect, predict, and prevent disease. The company was founded by Uday N. Kumar in September 2006 and is headquartered in San Francisco, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Blackford Quentin S. President and CEO Mar 03 '25 Sale 108.77 8,145 885,932 208,741 Mar 04 04:05 PM Rosenbaum Marc W. Chief Accounting Officer Mar 03 '25 Sale 108.77 314 34,154 11,507 Mar 04 04:05 PM Smith Mervin EVP Strategic Business Ops Mar 03 '25 Sale 108.77 638 69,395 16,454 Mar 04 04:04 PM Patterson Chad Chief Commercial Officer Mar 03 '25 Sale 108.77 2,756 299,770 58,440 Mar 04 04:03 PM Shrishrimal Sumi EVP, Chief Risk Officer Mar 03 '25 Sale 108.77 1,726 187,737 36,117 Mar 04 04:02 PM Turakhia Minang EVP, CMO & CSO Mar 03 '25 Sale 108.77 2,467 268,336 42,495 Mar 04 04:02 PM Wilson Daniel G. Chief Financial Officer Mar 03 '25 Sale 108.77 2,341 254,631 45,307 Mar 04 04:01 PM Patterson Chad Chief Commercial Officer Feb 26 '25 Sale 112.13 13,229 1,483,368 61,196 Feb 27 04:08 PM Patterson Chad Chief Commercial Officer Feb 25 '25 Sale 118.98 461 54,850 36,761 Feb 27 04:08 PM Shrishrimal Sumi EVP, Chief Risk Officer Feb 26 '25 Sale 112.13 7,942 890,536 37,843 Feb 27 04:07 PM Turakhia Minang EVP, CMO & CSO Feb 26 '25 Sale 112.13 7,014 786,480 44,962 Feb 27 04:06 PM Murphy Patrick Michael CBO and CLO Feb 26 '25 Sale 109.68 16,330 1,791,041 58,834 Feb 27 04:04 PM Blackford Quentin S. President and CEO Feb 26 '25 Sale 112.13 22,252 2,495,117 216,886 Feb 27 04:03 PM Wilson Daniel G. Chief Financial Officer Feb 26 '25 Sale 112.13 2,512 281,671 47,648 Feb 27 04:03 PM CHAD PATTERSON Officer Feb 25 '25 Proposed Sale 118.98 461 54,850 Feb 25 04:00 PM Murphy Patrick Michael CBO and CLO Dec 02 '24 Sale 85.89 2,492 214,038 35,327 Dec 03 03:45 PM TALWALKAR ABHIJIT Y Director Nov 04 '24 Buy 75.16 6,664 500,866 18,941 Nov 05 11:59 AM Blackford Quentin S. President and CEO Nov 04 '24 Sale 77.41 16,145 1,249,784 159,929 Nov 05 11:59 AM Bobzien Brice Chief Financial Officer Aug 09 '24 Sale 70.34 1,372 96,506 24,428 Aug 12 08:24 PM Patterson Chad Chief Commercial Officer May 31 '24 Buy 74.98 280 20,994 40,145 Aug 05 05:35 PM Patterson Chad Chief Commercial Officer Aug 02 '24 Sale 74.66 3,012 224,876 37,133 Aug 05 05:35 PM Smith Mervin EVP Strategic Business Ops Aug 02 '24 Sale 74.66 688 51,366 10,360 Aug 05 05:35 PM Turakhia Minang EVP, CMO & CSO Jul 02 '24 Sale 105.65 1,404 148,333 27,255 Jul 03 03:35 PM Rosenbaum Marc W. Chief Accounting Officer Jun 03 '24 Sale 88.91 510 45,344 8,174 Jun 05 12:40 PM Shrishrimal Sumi EVP, Chief Risk Officer Jun 03 '24 Sale 88.91 1,131 100,557 23,298 Jun 05 12:40 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite